TECHNICAL TREND ( NIFTY - BANK NIFTY FUTURES ) NIFTY FIFTY : The Equity benchmark has opened in a positive note on Monday, the Nifty50 is up by 10 points or 0.12 per cent at 8166. The Nifty has rallied almost 500 points in last six to seven trading sessions. But for the last four day’s, it has been facing some Resistance near the 8200 level. We may see the more correction and the index can come down to around 8023 level, which is 38.20 per cent retracement level of the entire rally from 7700 to 8200. Continues expectation of US positive data. Which increased the possibility of a rate hike by the Fed in next meeting. Data release on Thursday suggested domestic economy grew at 7.9 per cent in march quarter to help india achieve a five year high annual growth rate of 7.6 per cent. The ECB is maintain the status quo for the fourth Monetary policy review on Thursday on moderate Inflation and economic growth . The Nifty crucial levels for the upcoming week would be around 8100-8200 in down side and 8300-8350 is in Up side.
BANK NIFTY : - is planning to float a fund that will invest in sunk loans held by lenders, minister of state for finance Jayant Sinha said on Tuesday, as the authorities strive to clean up balance sheets of banks. Bank loan to the Industrial Sector remained almost flat with a mere 0.1 per cent growth in April , Validating these concern that lack of Industrial Projects is taking the fizz out the economy Reserve Bank of India data showed loans to industry growth is 5.9 per cent in the same period. The Bank Nifty trend seen the Upside in a daily chart we may witness the Bank Nifty level around 17900-18100 in the upcoming week. The Crucial Levels for Bank Nifty is 17450-17570 and Upside is 1780018000.
Monday, 06 June 2016
TECHNICAL VIEW (NIFTY- BANK NIFTY FUTURES ) NIFTY DAILY
WEEKLY
MONTHLY
R2
R1
PP
S1
S2
8379
8283
8235
8187
8091
R2
R1
PP
S1
S2
8589
8335
8208
8081
7827
R2
R1
PP
S1
S2
8530
8320
8215
8110
7900
R2
R1
PP
S1
S2
18034
17816
17707
17598
17380
R2
R1
PP
S1
S2
18016
17605
17194
16372
R2
R1
PP
S1
S2
18835
18013
17602
17191
16369
BANK NIFTY DAILY
WEEKLY
18838
MONTHLY
MOVING AVERAGE
21 DAYS
50 DAYS
100 DAYS
200 DAYS
NIFTY
7960
7855
7609
7801
BANK NIFTY
16897
16552
15765
16520
PARABOLIC SAR
DAILY
WEEKLY
MONTHLY
NIFTY
7925
7725
6894
BANK NIFTY
16717
15757
13525
PATTERN FORMATION ( NIFTY )
Detail of Chart On the above given chart of Nifty has applies Bollinger Band and MACD and made the Supportive Trend line these are the trend identifying pattern and made Support level in the Nifty daily chart that made on the above given chart we have draw the for day period and it is able to break the 8200 up level. However in upcoming trading session it could break the level of 8300 which is the strong Resistance for the Nifty50 around 8300-8350. Now we are expecting that if the Nifty is able to sustain the 8200 level we are witness the market in upcoming trading session can see the Bull trend of Nifty for some more sessions on the other hand if Nifty rebound the 8200-8250 level again we may see the positive rally in the index. The Strong Support for Nifty50 is 8150-8200 and the Resistance is 8300-8350.
PATTERN FORMATION ( BANK NIFTY )
Details of ChartOn the above given chart of Nifty has applies the MACD and Bollinger Band, the Bank Nifty is looking Bullish for the upcoming trading sessions of next week. these are the trend identifying pattern and made the high of this month Bank Nifty daily chart that made on the above given chart we have draw the trend line for more than the week period and if it is able to break the Uper levels 17750-17800. However in upcoming trading session it could break these level which is the strong Resistance for Bank Nifty around 17750-17800. Now we are expecting that if the Bank Nifty is able to sustain the 1760017650 level we may witness the consolidation trend of Bank Nifty for some more sessions on the other hand if Bank Nifty rebound the 17750-17860 level again we may see the positive rally in the index. The Strong Support for Bank Nifty is 17500-17560 and the Resistance is 17700-17900.
NSE EQUITY DAILY LEVELS COMPANY NAME
R2
R1
PP
S1
S2
ACC
EQ
1580
1570
1554
1544
1528
ALBK
EQ
53
52
51
50
49
AMBUJACEM
EQ
235
232
230
227
225
ASIAN PAINT
EQ
1042
1032
1023
1013
1004
AXISBANK
EQ
555
548
538
531
521
BAJAJ-AUTO
EQ
2823
2695
2631
2603
2567
BANKBARODA
EQ
146
143
142
139
138
BANKINDIA
EQ
89
87
85
83
82
BHEL
EQ
123
120
119
116
115
BHARTIARTL
EQ
369
365
360
356
351
CIPLA
EQ
475
471
469
465
463
COALINDIA
EQ
312
311
309
308
306
DLF
EQ
139
135
133
129
127
DRREDDY
EQ
3220
3190
3166
3136
3112
GAIL
EQ
380
375
373
368
366
GRASIM
EQ
4392
4356
4333
4297
4274
HCLTECH
EQ
728
725
722
719
716
HDFC
EQ
1278
1265
1256
1243
1234
HDFCBANK
EQ
1192
1182
1176
1166
1160
HEROMOTOCO
EQ
3244
3212
3180
3148
3116
HINDALCO
EQ
108
107
105
104
102
HINDUNILVR
EQ
899
891
880
872
861
ICICIBANK
EQ
248
246
244
242
240
ITC
EQ
362
358
355
351
348
INDUSIND BANK
EQ
1138
1131
1125
1118
1112
INFY
EQ
1288
1277
1269
1258
1250
JINDALSTEL
EQ
65
63
62
60
59
KOTAKBANK
EQ
791
780
762
751
733
LT
EQ
1497
1481
1468
1452
1439
M&M
EQ
1368
1362
1352
1346
1336
MRF
EQ
33868
33678
33489
33290
33110
MARUTI
EQ
4265
4241
4210
4186
4155
ONGC
EQ
215
214
212
211
209
ORIENTBANK
EQ
85
83
82
80
79
RCOM
EQ
52
50
49
48
47
RELCAPITAL
EQ
414
408
403
397
392
RELIANCE
EQ
966
962
959
955
952
RELINFRA
EQ
545
534
526
515
507
RPOWER
EQ
53
52
51
50
50
SBIN
EQ
205
200
198
193
191
SSLT( VEDL)
EQ
109
107
105
103
102
SUNPHARMA
EQ
757
746
741
730
725
TATAMOTORS
EQ
464
458
455
449
446
TATAPOWER
EQ
76
75
74
73
72
TATASTEEL
EQ
352
345
340
333
328
UNIONBANK
EQ
120
116
114
111
108
TOP 15 ACHIEVERS
SR.NO
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15
SCRIPT NAME
PREV CLOSE
CMP
//
SR.NO
% CHANGE
HINDALCO INDUS
91.90
105.55
+14.85 %
TATAMOTORS
403.90
453.95
+12.39 %
COAL INDIA LTD
281
308
+9.83 %
ADANI PORTS
191
204
+6.70 %
AXIS BANK LTD
512
542
+5.90 %
NTPC
140
147
+5.35 %
HERO MOTOCORP
3002
3146
+4.79 %
KOTAK BANK
742
769
+3.60 %
AUROBINDO
763
789
+3.50 %
TECH MAHINDRA
535
551
+2.95 %
BAJAJ AUTO LTD
2563
2639
+2.94 %
HUL
861
884
+2.75 %
TATA STEEL
329
338
+2.72 %
ASIANPAINTS LTD
998
1025
+2.71 %
YES BANK LTD
1025
1049
+2.33 %
1 T44+T44+T44+T442+T44 A051A051A051A051A05 T332T332T332T3332T33 A. . . A. . . A. . . A. . . A. . 1. 1 A1 A M 92 9+32. M1 92 9+33. M1 92 9+34. M 92 94+35. M1 92 9 D O9 00 56 9D O9 00 56 9D O9 00 56 9D O9 00 56 9D O9 00 5 A T14. A T14. A T14. A T145. A T14 N O 7 %N O 7 %N O 7 %N O 7 %N O N IR11+0N IR11+0N IR11+0N IR116+0N IR11 TP S445TP S445TP S445TP S445TP S44 P O07.%P O07.%P O07.%P O077.%P O07 C R 3C R 3C R 3C R 3C R K T77+5K T77+5K T77+5K T778+5K T77 O S463O S463O S463O S463O S46 T29.%T29.%T29.%T299.%T29 A 6A 6A 6A 6A TK55+0TK55+0TK55+0TK55 +0TK55 10 352 352 352 352 35 E E E E E .%B51 B51.%B51.%B51.%B51 11 C A 9C A 9C A 9C A 9C A H 88+5H88+5H 88+5H88 +5H88 N H N H N H N H 12N H K682U K682U K682U K682U K68 U 14.% 14.% 14.% 14 . % 14 13 L 7L 7L 7L 7L M M91+A M M +A M A 91+5A 5 91+5A91 5 91 14 902A902A902A902A90 A S S S S S 82.% 82.% 82.% 82.% 82 H I 57H I 57H I 57H I 15 I 5 57H IA 1IA 1IA 1IA 1IA
TOP 15 LOOSERS
SCRIPT NAME
PREV CLOSE
SUN PHARMA
824
737
BHEL
128
118 -7.88 %
IDEA CELLULAR
113
105
757
721
GAIL
379
370
LUPIN
1480
1450
ULTRATECH
3248
3189
CIPLA
473
465
RELIANCE
974
959
ITC LTD
359
353
HDFC BANK
1186
1171
L&T
1474
1460
WIPRO
545
540
AMBUJA CEMENT
230
228
ONGC
213
211
-6.68 % AHCLATECH A
-4.71 % -2.39 % -2.03 % -1.82 % -1.74 % -1.54 % -1.50 % -1.27 % -0.97 % -0.84 %
NEXT WEEK STARS (AS PER ECHNICAL ANALYSIS PRIDICTION) +13.67 AMBUJA CEMENT AM 204 232 Futures Pack % BUJ 18128 20371 2. B +12.37 3. B 12+4.12+5.12+6.12+7. B12+B B B N N N N N % 1 1 1 1 A NSE CASH : BUY NETWORK18 ABOVE 43 TGT 46.80 SL 41.70 8T0O8T0O8T0O8T0O8T01 ACC 1240 1385 O +11.68 OSCH ACC 2 2 2 2 2 CEM S % LTD. 1S3. S1S3. S1S3. S321 1S3. S1S3TGT NSE CASH : BUY SOBHA LIMITED NSE CASH ABOVE 346 SL 312. . ENT C 2 7 C 2 7 C 2 7 C 2 7 C 2 7 3 3 262 3 SL 234. NSE CASH : BUY KIRIINDUS NSE CASH ABOVE 32413 TGT H 8L17H8L17H8L17H8L17H8L17 NSE CASH : BUY MONSANTO NSE CASH ABOVE 2500 TGT 2750 SL 2425. T
T
T
T
%D510 % NSE CASH : BUY RAMCOCEM 558 SL 495. L NSE CASH ABOVE LD %TGT LD %LD % D L
Cash Pack
T D .
% CHANGE
-10.62 %
N %N N %N N %N N %N N N D D P D P D P D P P R R R R A A A A R A A I A I A I A I A I
T
CMP
TTTT DDDD . . . .
NSE FUTURE : BUY NCC FUTURE ABOVE 73.10 TGT 74.40 SL 72.50 NSE FUTURE : BUY TATAELXSI FUTURE ABOVE 1827 TGT 1860 SL 1818 NSE FUTURE : BUY HINDALCO FUTURE ABOVE 107.30 TGT 109 SL 106.80 NSE FUTURE : BUY MCLEODRUSS FUTURE ABOVE 184 TGT 190 SL 181 NSE FUTURE : BUY JISLJALEQS FUTURE ABOVE 66.50 TGT 67.50 SL 66
-0.69 % -0.54 %
111- 211- 311- 4B11- 5 B11 H217H217H217H217H21 E88. E88. E88. E88. E88 L 8L 8L 8L 8L H77-8H77-8H77-8H77-8H77 C524C524C524C524C52 L71.%L71.%L71.%L71.%L71 7T 7T 7T 7T LT11-1LE11-1LE11-1LE11-1LE11 U E442U C442U C442U C442U C44 P C85.%P H85.%P H85.%P H85.%P H85 IH000I 000I 000I 000I 00 C N44-3C N44-3C N44-3C N44-3C N44 I 761I 761I 761I 761I 76 P35.%P35.%P35.%P35.%P35 L 7L 7L 7L 7L IA33-4IA33-4IA33-4IA33-4IA33 T551T551T551T551T55 C93.%C93.%C93.%C93.%C93 5 5 5 5 L11-0L11-0L11-0L11-0L11 & T440& T440& T440& T440& T44 TD76.%TD76.%TD76.%TD76.%TD76 409 409 409 409 40 A22-7A22-7A22-7A22-7A22 M 320M320M320M320M32 B08.%B08.%B08.%B08.%B08 U 6U 6U 6U 6U J 9J 9J 9J 9J A A A A A % % % % C C C C C E E E E E M M M M M E E E E E N N N N N T T T T T
NSE - WEEKLY NEWS LETTERS ✍ TOP NEWS OF THE WEEK US Foreign Portfolio Investors ask india to amend capital gains tax treaty - Foreign portfolio investors based out of the US have collectively approached the India with a request to amend the India-US tax treaty, exempting them from paying capital gains tax , people close to the development said. These investors — mainly pension funds —are those who had invested in Indian equities through Mauritius route. They say the India-US treaty should be amended in a way that there's no capital gains on those investors who do not pay taxes back home in the US. They also expressed their wish to directly come to India rather than route through an investment vehicle based in a third country such as Mauritius or Singapore, a person in the know said. Most Asia Pacific Banks have buffers against commodity Risk - Moody’s - Moody's Investors Service says that banks in Asia Pacific show moderate loan exposure to borrowers in commodity-related industries, with such loans making up around 7% of gross loans on average at end-2015.However, the quality of such loans will likely continue to deteriorate, based on Moody's assessment that energy and commodity prices will remain low over a prolonged period.
Indian Companies raised a records Rs. 4.92 lakh crore last fiscal through Private Placement in FY’16 - Indian companies raised a record Rs 4.92 lakh crore last fiscal through private placement of corporate bonds to meet business needs, a surge of six per cent from the preceding year. Firms raked in Rs 4,92,047 crore in 2015-16 through private placement of corporate bonds, higher than Rs 4.66 lakh crore garnered in the preceding financial year ended March 2015, as per a report by Prime Database.This was the highest ever fund raising by companies in a financial year since 2001-02, when the firms had raked in Rs 45,427 crore. RBI to Lower by Another 50 Bps in FY-17 - Morgan Stanley - The Reserve Bank is expected to keep key rates unchanged in the next policy meeting on June 7, but might lower rates by another 50 bps during the current financial year, says a report by Morgan Stanley.According to the report, retail inflation is likely to moderate going forward and is expected to decelerate to 4.5 per cent by March 2017. "Based on our CPI forecast and RBI's stated real rate target of 1.5-2 per cent, we expect RBI to lower rates by another 50 bps in FY2017," Morgan Stanley said in a research note.
Indian Economy to Grow at 7.7 per cent in this Fiscal - Survey - Indian Economy will grow 7.7 per cent in the ongoing fiscal Amid likely improvement in the Industrial and Agricultural sectors, Performance on Account of Good Monsoon, Though the investment cycle is expected to take at least a months to witness a Pick-Up. Say a Survey. “The Growth in 2016-17 is expected to be Supported by and improvement in the Agricultural and Industrial Sector Performance. Prediction of a Good Monsoon, After two consecutive years of sub-optimal rainfall back the improve outlook in the current fiscal.
� TOP ECONOMY NEWS
The country's first Nuclear Operator's Liability Policy has been issued to Nuclear Power Corporation of India, underwritten by a consortium of insurance companies through the India Nuclear Insurance Pool.
Foreign direct investment into India increased by 16.5% to USD 2.46 billion in March this year.
Indian IT companies would have to pay at least an additional USD 4,000 for every H-1B visa application under the new regulations that came into effect last December.
The Central Board of Direct Taxes on Friday issued a series of clarifications for the roll out of the Foreign Account Tax Compliance Act and the Common Reporting Standards, based on its interaction with financial institutions.
The
Centre is actively considering proposals of four public sector general insurance
companies to be part of the Pradhan Mantri Fasal Bima Yojana launched this year.
Mineral
bearing states have collected penalty of the order of Rs. 11.71 billion from
illegal mining activities between 2012-13 and 2015-16 till the end of September 2015.
The
country's economy grew 7.6% in 2015-16, at the same rate pegged by advance
estimates, compared to 7.2% in the previous year.
Indicating better tidings for the economy, the eight core sector industries grew 8.5% in April this year with refinery products and electricity registering double digit growth.
The Central Drug Standard Control Organisation is drawing up a new inspection model for pharmaceutical manufacturing sites that will help identify compliance issues and products that can be potentially harmful. The move follows concerns raised by foreign drug regulator over quality of medicines produced in India.
The general framework agreement for Kudankulam Nuclear Power Plant's Units 4 and 5 would be signed this year while negotiations were underway over configuration of Units 5 and 6, a Russian firm designing the Tamil Nadu-based atomic plant.
✍ TOP CORPORATE NEWS Battling pricing pressures in the US and at home, drug-maker Sun Pharmaceutical Industries has projected a revenue growth of 8-10 per cent in the year ahead. “I see traction in all parts of the business,” Dilip Shanghvi, Managing Director said. giving a guidance on the company’s growth prospects, taking into account remediation efforts at Sun’s Halol plant and the end of sales exclusivity on cancer drug Imatinib in the US. He also indicated that the recent acquisition of Novartis products in Japan would contribute to the company’s revenues later in the financial year.
Glenmark Pharmaceuticals launched an offer on the Singapore Stock Exchange to raise up to $200 million (over Rs 1,340 crore) through issue of securities. The Mumbai-based company has decided on a regulatory floor price for conversion of the FCCB at Rs 861.84. The company, however, did not disclose the reason for the fund-raising.
Maruti Suzuki Limited has reported the Sales Growth of 10-13 per cent in April-May led by demand in the Domestic market and the Launch of the New Models Like Vitara Brezza. Drug maker Unichem Laboratories has earmarked a capital expenditure of around Rs 200 crore for the current fiscal, most of which would go into the company's upcoming API plant in Kolhapur, Maharashtra."In the current year we are looking at around Rs 150200 crore of capex which may get spilled over to FY2018 also," Unichem Laboratories VP finance and CFO Rakesh Pankh said. The API unit is coming up and it has a major capital expenditure, he said, adding that "the work out there is going on in full swing".
The Sun Pharmaceutical Industries Ltd stock fell 6.13% on NSE on Tuesday, after the announcement of the company’s results on Monday. What led to the plunge? It wasn’t the
company’s 1.8% sales growth in FY16, because that was not much of a surprise, as the management had indicated as much. What shocked investors is its sales growth projection for FY17. An 8-10% sales growth is not what they expected, and even a proposed share buyback did little to lift spirits.
Aurobindo Pharma plans to focus on increased Abbreviated New Drug Application filings and new differentiated product launches to maintain growth. The company posted a growth of 15% in sales and 26% in profit in the fiscal year ended March 2016.
Global alternative asset manager Apollo Global Management LLC is seeking a licence to start an asset reconstruction company in India, two people directly familiar with the matter said. Apollo is one of a number of firms looking at entering the stressed assets business in India as banks try to clean up their balance sheets. Apollo Global confirmed that it is considering the option.
� TOP BANKING AND FINANCIAL NEWS OF THE WEEK
Private sector has shone through the mayhem plaguing their public sector counterparts in the past two years with new generation banks substantially outperforming their older peers, riding on demand for consumer loans and is not weighed down by legacy issues.
Over the last two years, the Modi government has brought private bankers to head the top-five PSU banks, passed the Bankruptcy Bill, initiated consolidation among PSU banks and set up a professional board to hire top management. Many bankers say all these measures could create positive sentiments which will result in the revival of the Indian economy.
LEGAL DISCLAIMER
This Document has been prepared by Ways2Capital (A Division of High Brow Market Research Investment Advisor Pvt Ltd). The information, analysis and estimates contained herein are based on Ways2Capital Equity/Commodities Research assessment and have been obtained from sources believed to be reliable. This document is meant for the use of the intended recipient only.
This document, at best, represents Ways2Capital Equity/Commodities Research opinion and is meant for general information only. Ways2Capital Equity/Commodities Research, its directors, officers or employees shall not in any way to be responsible for the contents stated herein. Ways2Capital Equity/Commodities Research expressly disclaims any and all liabilities that may arise from information, errors or omissions in this connection. This document is not to be considered as an offer to sell or a solicitation to buy any securities or commodities.
All information, levels & recommendations provided above are given on the basis of technical & fundamental research done by the panel of expert of Ways2Capital but we do not accept any liability for errors of opinion. People surfing through the website have right to opt the product services of their own choices.
Any investment in commodity market bears risk, company will not be liable for any loss done on these recommendations. These levels do not necessarily indicate future price moment. Company holds the right to alter the information without any further notice. Any browsing through website means acceptance of disclaimer.
DISCLOSURE High Brow Market Research Investment Advisor Pvt. Ltd. or its associates does not do business with companies covered in research report nor is associated in any manner with any issuer of products/ securities, this ensures that there is no actual or potential conflicts of interest. To ensure compliance with the regulatory body, we have resolved that the company and all its representatives will not make any trades in the market. Clients are advised to consider information provided in the report as opinion only & make investment decision of their own. Clients are also advised to read & understand terms & conditions of services published on website. No litigations have been filed against the company since the incorporation of the company.
Disclosure Appendix: The reports are prepared by analysts who are employed by High Brow Market Research Investment Advisor Pvt. Ltd. All the views expressed in this report herein accurately reflects personal views about the subject company or companies & their securities and no part of compensation was, is or will be directly or indirectly related to the specific recommendations or views contained in this research report.
Disclosure in terms of Conflict of Interest: (a) High Brow Market Research Pvt. Ltd. or his associate or his relative has no financial interest in the subject company and the nature of such financial interest; (b) High Brow Market Research Pvt. Ltd. or its associates or relatives, have no actual/beneficial ownership of one percent or more in the securities of the subject company, (c) High Brow Market Research Pvt. Ltd. or its associate has no other material conflict of interest at the time of publication of the research report or at the time of public appearance;
Disclosure in terms of Compensation: High Brow Market Research Investment Advisor Pvt. Ltd. policy prohibits its analysts, professionals reporting to analysts from owning securities of any company in the analyst's area of coverage. Analyst compensation: Analysts are salary based permanent employees of High Brow Market Research Pvt. Ltd.
Disclosure in terms of Public Appearance: (a) High Brow Market Research Pvt. Ltd. or its associates have not received any compensation from the subject company in the past twelve months; (b) The subject company is not now or never a client during twelve months preceding the date of distribution of the research report. (c) High Brow Market Research Pvt. Ltd. or its associates has never served as an officer, director or employee of the subject company; (d) High Brow Market Research Pvt. Ltd. has never been engaged in market making activity for the subject company.